Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2012


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


The Globalization of US Medical Countermeasure Production and Its Implications for National Security

Amesh A. Adalja, Samuel B. Wollner, Thomas V. Inglesby, George Poste
Date posted:
September 11, 2012
Publication type:

Biosecur Bioterror 2012;10(3):255-257

Mary Ann Liebert, Inc.
Open access
See also:

Full article available on publisher's site: HTML • PDF


Recent cases of counterfeit and contaminated medications have raised concerns about the integrity of the US supply chain of pharmaceuticals. Moreover, shortages in oncology drugs have highlighted a weak domestic production capacity for essential medications. The FDA and the Pew Charitable Trusts have published analyses of the problems as they relate to the US's regulatory system and healthcare industry. These issues also represent a potential national security threat.



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.